Results 161 to 170 of about 68,677 (270)

Generic amyloid fibrillation of TMEM106B in patient with Parkinson's disease dementia and normal elders. [PDF]

Cell Res, 2022
Fan Y, Zhao Q, Xia W, Tao Y, Yu W, Chen M, Liu Y, Zhao J, Shen Y, Sun Y, Si C, Zhang S, Zhang Y, Li W, Liu C, Wang J, Li D.   +16 more
europepmc   +1 more source

Aging and periodontitis increase brain dissemination of oral bacteria

Journal of Periodontology, EarlyView.
Abstract Background The microbiome is a dynamic system that changes throughout life. Studies have revealed the relationship between periodontal disease and the oral microbiota; however, the impact of periodontal disease on the expression of senescence markers and on the inflammaging of the oral and systemic microbiome remains unclear.
Ozge Unlu, Tsute Chen, Nil Yakar, Zeliha Guney, Bruce Paster, Isabel Carreras, Alpaslan Dedeoglu, Alpdogan Kantarci   +7 more
wiley   +1 more source

Is There the Preventive Effect of COMT-inhibitor on Parkinson’s Disease Associated with Dementia?

, 2012
Background: Elevated homocysteine (hcy) levels are associated with dementia, which is a frequent non-motor symptom of Parkinson’s disease (PD). High levels of hcy in PD patients treated with levodopa are thought to result from increased synthesis during ...
In-uk Song, Sung-woo Chung, Hyun-jo Lee, Neurocognitive Disorder, Young-do Kim, Young-soon Yang, Hyun-ji Cho   +6 more
core  

Parkinson's Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron. [PDF]

Front Aging Neurosci, 2021
Han J, Fan Y, Wu P, Huang Z, Li X, Zhao L, Ji Y, Zhu M.   +7 more
europepmc   +1 more source

Neuroprotective effects of quercetin in animal models of neurodegenerative diseases: A systematic review and meta‐analysis

Journal of the Science of Food and Agriculture, EarlyView.
Abstract Neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease are characterized by progressive neuronal loss driven by oxidative stress and inflammation. Quercetin, a dietary flavonoid with established antioxidant and anti‐inflammatory properties, has emerged as a potential neuroprotective agent.
In Ho Cho, Hendra Mahakam Putra, Cheol Woon Jung, Gyu Hwan Hyun, Hwan‐Hee Jang, In Guk Hwang, Sung Won Kwon   +6 more
wiley   +1 more source

EEG microstate alterations in Parkinson's disease dementia. [PDF]

Sci Rep
Zhao Y, Xu J, Xu X, Song J, Cai J, Shi H, Wei W, Xue X.   +7 more
europepmc   +1 more source

Epidemiological Signals, Knowledge Gaps, and Practice Considerations From the 2024 Functional Neurological Disorder Society International Meeting: A Conference Report With Narrative Synthesis

Medicine Bulletin, EarlyView.
ABSTRACT The 2024 International Conference on Functional Neurological Disorders brought together clinicians, researchers, advocates, and service‐user representatives to discuss recent developments in functional neurological disorder and related functional disorders.
Yadira Velazquez‐Rodriquez, Jennifer Brown, Katherine Gill   +2 more
wiley   +1 more source

Parkinson's disease dementia and hearing impairment, are they related? A UK biobank pilot analysis. [PDF]

Exp Brain Res
Readman MR, Giebel C, Cannon J, Fairman I, Plack CJ.   +4 more
europepmc   +1 more source

Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia. [PDF]

Nat Commun, 2021
Gasca-Salas C, Fernández-Rodríguez B, Pineda-Pardo JA, Rodríguez-Rojas R, Obeso I, Hernández-Fernández F, Del Álamo M, Mata D, Guida P, Ordás-Bandera C, Montero-Roblas JI, Martínez-Fernández R, Foffani G, Rachmilevitch I, Obeso JA.   +14 more
europepmc   +1 more source

Comparing phenotypic features between Parkinson's disease dementia and dementia with Lewy bodies. [PDF]

J Neurol
Gunawardana CW, Burke PGR, Ignatavicius A, Matar E, Lewis SJG.   +4 more
europepmc   +1 more source